Home Renalytix

Renalytix

In operation
Post-IPO Round
Developer of Artificial Intelligence Clinical Diagnosis Solutions

Basic Information

RenalytixAI is a company that develops artificial intelligence (AI) clinical diagnostic solutions, which can be used for the diagnosis of kidney diseases. Kidney disease is one of the most common and costly chronic conditions globally. RenalytixAI's solution aims to significantly improve risk assessment, clinical care, and patient stratification for drug clinical trials in kidney diseases.RenalytixAI's technology platform will utilize various sources of patient data, including large electronic health records, predictive blood-based biomarkers, and other genomic information, analyzed through machine learning algorithms. RenalytixAI intends to build a deep and unique pool of kidney disease-related data for different AI applications, aiming to enhance predictive capabilities and clinical applications over time.
Renalytix AI plc.
London,England,United Kingdom
15~50 people
January 01, 2018
renalytix@walbrookpr.com